• GANT61 GLI Inhibitor: Advanced Protocols for Cancer Research

  2026-05-12

  GANT61 is a selective GLI inhibitor that empowers cancer researchers to dissect Hedgehog pathway signaling and overcome immunotherapy resistance. This guide translates cutting-edge findings into actionable protocols, highlighting troubleshooting insights for robust GLI-mediated transcription inhibition and tumor growth suppression.

• BX795: PDK1 Inhibition and Beyond for Translational Research

  2026-05-12

  This article explores BX795 as a multi-kinase inhibitor, highlighting its mechanistic impact on innate immunity and cancer signaling while offering strategic guidance for translational researchers. Drawing on recent findings—including the role of TBK1 in HBV immune evasion—we provide evidence-based insights, protocol parameters, and a critical perspective on BX795’s unique position in the landscape of PI3K/Akt/mTOR and innate immune pathway modulation.

• PLK1-Mediated Phosphorylation of p31comet Regulates Mitotic

  2026-05-11

  This study elucidates how Polo-like kinase 1 (PLK1) phosphorylates p31comet to control the disassembly of mitotic checkpoint complexes (MCCs), offering mechanistic insight into cell cycle regulation. The findings advance our understanding of mitotic checkpoint inactivation and suggest new avenues for targeting PLK1 in cancer research.

• Veratridine in Neurotoxicity Modeling: Mechanisms, Assay Des

  2026-05-11

  Explore how Veratridine, a voltage-gated sodium channel opener, enables precise modeling of excitotoxicity and neuronal injury. This article uniquely dissects mechanistic insights and assay optimization strategies, advancing sodium channel dynamics research beyond existing guides.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Proto

  2026-05-10

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) safeguards proteins during extraction by inhibiting a broad range of proteases without interfering with divalent cation-dependent assays. This product is essential for workflows like Western blotting, co-immunoprecipitation, and kinase assays, but should not be used where EDTA-based inhibition is specifically required.

• Saracatinib Blocks Necroptosis via MLKL Targeting in Psoriat

  2026-05-09

  This study identifies saracatinib as a novel inhibitor of necroptosis, acting through direct targeting of MLKL to suppress inflammatory cell death and ameliorate psoriatic skin inflammation. The findings suggest new avenues for drug repositioning and mechanistic screening in inflammatory and cell death-related diseases.

• Cyclo (-RGDfC) (SKU A8790): Data-Driven Solutions in Cell As

  2026-05-09

  This article delivers scenario-based, evidence-backed guidance for biomedical researchers using Cyclo (-RGDfC) (SKU A8790) in cell viability, proliferation, and cytotoxicity assays. We address real laboratory challenges—such as integrin specificity, peptide stability, and data reproducibility—demonstrating how Cyclo (-RGDfC) from APExBIO enables robust, high-fidelity experimental workflows.

• Ibrexafungerp Retains Antifungal Activity at Vaginal pH in V

  2026-05-08

  This study demonstrates that ibrexafungerp (MK 3118) maintains potent in vitro activity against both fluconazole-susceptible and -resistant vaginal Candida isolates at acidic pH, a condition that typically reduces efficacy of standard antifungals. These findings highlight ibrexafungerp’s translational relevance for treating vulvovaginal candidiasis, particularly in azole-resistant contexts.

• E-64d: Enabling Precision in Lysoptosis and Cell Death Resea

  2026-05-07

  This thought-leadership article explores how E-64d, a membrane-permeable cysteine protease inhibitor from APExBIO, empowers translational researchers to dissect emerging cell death pathways such as lysoptosis with mechanistic precision. Integrating the latest insights on lysosomal membrane permeabilization and cathepsin biology, the article delivers evidence-based strategies for experimental design, highlights workflow best practices, and maps the translational impact across neuroprotection, oncology, and platelet biology. Strategic guidance is provided on protocol optimization, leveraging APExBIO’s E-64d for robust, reproducible results, and positioning research at the forefront of regulated cell death science.

• Tetrahedral DNA Frameworks Enhance Enzymatic Oligonucleotide

  2026-05-07

  This study introduces a tetrahedral DNA nanostructure (TDN) interface that markedly improves enzymatic oligonucleotide synthesis (EOS) efficiency and fidelity. By optimizing primer orientation and reducing spatial hindrance for enzymes, the approach yields longer, more accurate DNA strands, advancing applications in DNA storage and molecular diagnostics.

• Escitalopram in Antidepressant Research: Protocols & Insight

  2026-05-06

  Escitalopram stands out as a precision tool for dissecting serotonergic signaling in depression and anxiety models. This guide synthesizes robust protocol enhancements, advanced troubleshooting, and the latest translational findings—empowering researchers to drive reproducible and innovative antidepressant studies.

• HOBt (1-Hydroxybenzotriazole): Precision Tools for Amide Syn

  2026-05-06

  Explore the advanced role of HOBt (1-Hydroxybenzotriazole) in precise amide bond formation, with unique insight into its mechanistic advantages for both peptide synthesis and complex small-molecule assembly. This article reveals new assay design considerations and best practices for minimizing epimerization in cutting-edge research.

• Streptavidin – Cy5: High-Precision Biotin Detection Workflow

  2026-05-05

  Streptavidin – Cy5, featuring the Cy5 fluorescent dye, delivers ultra-sensitive biotin detection for advanced immunofluorescence and flow cytometry. This guide translates recent breast cancer research breakthroughs into practical, optimized assay workflows—empowering your lab with robust, reproducible performance.

• Tofacitinib (CP-690550): Advancing Mitochondrial Repair in R

  2026-05-05

  Explore how Tofacitinib (CP-690550) uniquely modulates mitochondrial dynamics and inflammation in rheumatoid arthritis macrophages. This article offers an in-depth scientific analysis and practical assay guidance for immune modulation research.

• Methoxy-X04: Fluorescent Amyloid Beta Probe for Enhanced Ima

  2026-05-04

  Methoxy-X04 is transforming Alzheimer's research by enabling selective, high-contrast visualization of amyloid-beta pathology in vivo and ex vivo. This article delivers actionable workflows, protocol optimization, and troubleshooting strategies to maximize the probe’s impact in neurodegeneration studies.

445 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page